chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 12.0
Sex: M
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of gave expired FLUMIST was received from a nurse concerning a 12-year old male. On 03-Feb-2010, the patient received FLUMIST that expired on 2-Feb-2010. There is no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. No late occurring adverse events were reported. Additional information was received on 11-May-2010 and incorporated into the narrative: information on late occurring adverse events.
Age: 5.0
Sex: F
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of inadvertent administration of expired FLUMIST was received from a health professional concerning a five-year-old female patient. The product expired on 07-Feb-2010 and on 16-Feb-2010 the patient received expired product. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Sex: F
Vaccine: FLUN3
Symptoms: Accidental exposure, Malaise
Clinical narrative: A non-serious, spontaneous report of accidental exposure while administering drug and "got sick" has been received from a company representative concerning an adult female nurse subsequent to FLUMIST administration. Medical history and concomitant medications were not reported. The patient administered FLUMIST to other people several times over the past two years. The patient reported that if she did not wear a mask while administering FLUMIST, she would "get sick". She believed she became ill due to close proximity to patients during FLUMIST administration. No additional information was available. The company representative reported that the nurse believed she became sick due to exposure to FLUMIST (related). The outcome of the events was not reported.
Age: 10.0
Sex: M
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of inadvertent administration of expired FLUMIST was received from a healthcare professional concerning a 10-year-old male. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 02-Feb-Jan-2010 and was administered to the patient on 19-Feb-2010. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Age: 5.0
Sex: M
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of "inadvertent administration of expired FLUMIST" was received from a certified medical assistant concerning a five-year-old male. The patient's medical history and concomitant medications were not reported. On 23-Feb-2010, the patient was inadvertently administered a dose of expired FLUMIST. The product expired on 17-Feb-2010. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Age: 12.0
Sex: F
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of administration of expired product was received from a clinic administrator concerning a 12-year-old female subsequent to the administration of FLUMIST. The patient's medical history and concomitant medications were not reported. On 22-Feb-2010, the patient was administered FLUMIST. There was no adverse event associated with this vaccination error; therefore treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. No late occurring adverse events were reported. Additional information was received on 13-May-2010 and incorporated into the narrative: information on late occurring adverse events.
Age: 5.0
Sex: F
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of administration of expired product was received from a clinic administrator concerning a 5-year-old female subsequent to the administration of FLUMIST. The patient's medical history and concomitant medications were not reported. On 22-Feb-2010, the patient was administered FLUMIST. There was no adverse event associated with this vaccination error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. No late occurring adverse events were reported. Additional information was received on 13-May-2010 and incorporated into the narrative: information on late occurring adverse events.
Age: 6.0
Sex: M
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of administration of expired product was received from a clinic administrator concerning a 6-year-old male subsequent to the administration of FLUMIST. The patient's medical history and concomitant medications were not reported. On 22-Feb-2010, the patient was administered FLUMIST. There was no adverse event associated with this vaccination error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. No later occurring adverse events were reported. Additional information was received on 13-May-2010 and incorporated into the narrative: information on late occurring adverse events.
Age: 52.0
Sex: M
Vaccine: FLUN3
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: A non-serious report of "FLUMIST was administered to a 52-year-old person" was received from a health care professional concerning a 52-year-old male. The patient's medical history and concomitant medications were not reported. The patient was inadvertently administered FLUMIST on 01-Nov-2009. There was no adverse event associated with this event; therefore, treatment and causality assessments are not applicable, and the event is considered resolved.
Age: 8.0
Sex: F
Vaccine: FLUN3
Symptoms: Dermatitis contact, Gianotti-Crosti syndrome, Papule, Pruritus, Rash
Clinical narrative: A non-serious report of Gianotti-Crosti syndrome was received from a literature article concerning an eight-year-old female subsequent to the administration of FLUMIST. The patient had no history of hepatitis, atopy, upper respiratory symptoms, pharyngitis, gastrointestinal symptoms, or fever and chills. Concomitant medications were not reported. On an unknown date, the patient received FLUMIST intranasal. Six weeks later, a persistently pruritic plaque had appeared on the child's abdomen; which was attributed to nicklel dermatitis. Three weeks later, she developed pruritic papules on her face, which spread to her upper chest and upper arms bilaterally. Cephalexin was prescribed by the child's pediatrician for a possible bacterial skin infection. A week later, she was seen at a dermatology clinic for the rash on her face and arms which was worsening. On physical examination, there were excoriated papules and light pink papules about 1-2 mm in size, symmetrically distributed on the forehead, cheeks, chin, upper chest, and extensor surfaces of the arms bilaterally. There also was a well demarcated, pink, scaly plaque above the umbilicus. The diagnosis was thought to be most consistent with Gianotti-Crosti syndrome. Treatment with hydrocortisone 2.5% cream and diphenhydramine were prescribed as needed for pruritus. Two weeks after the initial presentation, the cutaneous findings were almost completely resolved. Rechallenge was not applicable for this product because re-administration of the product was not reported. The reporter assessed that the event could have potentially been related to the administration of FLUMIST. The company assessed the event as possibly related to the administration of FLUMIST.
Age: 8.0
Sex: F
Vaccine: FLUN3
Symptoms: Skin plaque
Clinical narrative: A non-serious report of Gianotti-Crosti syndrome was received from a literature article concerning an eight-year-old female subsequent to the administration of FLUMIST. The patient had no history of hepatitis, atopy, upper respiratory symptoms, pharyngitis, gastrointestinal symptoms, or fever and chills. Concomitant medications were not reported. On an unknown date, the patient received FLUMIST intranasal. Six weeks later, a persistently pruritic plaque had appeared on the child's abdomen; which was attributed to nicklel dermatitis. Three weeks later, she developed pruritic papules on her face, which spread to her upper chest and upper arms bilaterally. Cephalexin was prescribed by the child's pediatrician for a possible bacterial skin infection. A week later, she was seen at a dermatology clinic for the rash on her face and arms which was worsening. On physical examination, there were excoriated papules and light pink papules about 1-2 mm in size, symmetrically distributed on the forehead, cheeks, chin, upper chest, and extensor surfaces of the arms bilaterally. There also was a well demarcated, pink, scaly plaque above the umbilicus. The diagnosis was thought to be most consistent with Gianotti-Crosti syndrome. Treatment with hydrocortisone 2.5% cream and diphenhydramine were prescribed as needed for pruritus. Two weeks after the initial presentation, the cutaneous findings were almost completely resolved. Rechallenge was not applicable for this product because re-administration of the product was not reported. The reporter assessed that the event could have potentially been related to the administration of FLUMIST. The company assessed the event as possibly related to the administration of FLUMIST.
Age: 6.0
Sex: M
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of "administration of expired product" was received from a registered nurse concerning a six-year-old male subsequent to FLUMIST. The patient's medical history and concomitant medications were not reported. The product expired on 19-Jan-2010. On 27-Jan-2010, the patient received expired product. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Age: 12.0
Sex: F
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of administration of expired FLUMIST was received from a registered nurse concerning a 12-year old female patient. Neither relevant medical history nor concomitant medications have been reported for this patient. On 05-Jan-2010, the patient received FLUMIST (expiration date 31-Dec-2009). There was no adverse event associated with this medication error; treatment and reporter/sponsor causality assessments are not applicable, and the events are considered resolved.
Age: 10.0
Sex: F
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of administration of expired FLUMIST was received from a registered nurse concerning an approximately ten-year-old female patient. Neither relevant medical history nor concomitant medications have been reported for this patient. On 05-Jan-2010, the patient received FLUMIST (expiration date 31-Dec-2009). There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the events are considered resolved.
Age: 10.0
Sex: M
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of administration of expired FLUMIST was received from a registered nurse concerning an approximately ten-year-old male patient. Neither relevant medical history nor concomitant medications have been reported for this patient. On 05-Jan-2010, the patient received FLUMIST (expiration date 31-Dec-2009). There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the events are considered resolved.
Age: 8.0
Sex: M
Vaccine: FLUN3
Symptoms: Condition aggravated, Pneumonia
Clinical narrative: A non-serious spontaneous report of pneumonia has been received from a registered nurse concerning her eight-year-old son, subsequent to FLUMIST. The patient's past medical history included meconium aspiration and pneumonia at three-years-old. The patient received FLUMIST in Oct-2008. In Nov-2008, the patient developed pneumonia which was treated with antibiotics. The event resolved two weeks after the onset. The reporter was not sure if the event was related to FLUMIST.
Age: 18.0
Sex: M
Vaccine: FLUN(H1N1), FLUN3
Symptoms: Accidental exposure, Flushing, Malaise
Clinical narrative: A non-serious spontaneous report of environmental exposure to seasonal FLUMIST and H1N1 while administering vaccines, flushing and malaise has been received from a registered nurse concerning himself, an 18-year-old male, subsequent to administering FLUMIST and H1N1, Intranasal. Medical history and concomitant medications were not reported. The reporter administered FLUMIST and H1N1, Intranasal from Nov-2009 to Dec-2009. On 09-Nov-2009, the patient reported that he developed flushing and malaise after administering numerous doses of FLUMIST and H1N1 to vaccinees. The outcome of flushing and malaise was not provided. The reporter indicated that his symptoms may have been due to the environmental exposure to FLUMIST and H1N1.
Age: 8.0
Sex: F
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of inadvertent administration of expired FLUMIST was received from a licensed practical nurse concerning an eight-year-old female. The product expired on 19-Jan-2010. On 20-Jan-2010, the patient received expired product. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Age: 12.0
Sex: M
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of inadvertent administration of expired FLUMIST was received from a licensed practical nurse concerning a 12-year-old male. The product expired on 19-Jan-2010. On 20-Jan-2010, the patient received expired product. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Age: 7.0
Sex: M
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of inadvertent administration of expired FLUMIST was received from a licensed practical nurse concerning a sever-year-old male. The product expired on 19-Jan-2010. On 20-Jan-2010, the patient received expired product. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessment are not applicable, and the event is considered resolved.
Age: 21.0
Sex: M
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of inadvertent administration of expired FLUMIST was received from a registered nurse concerning a 21-year-old male. The product expired on 05-Jan-2010. On 25-Jan-2010 the patient received expired product. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Age: 15.0
Sex: M
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of administration of expired dose of FLUMIST was received from a healthcare professional concerning a 15-year-old male. Neither relevant medical history or concomitant medications have been reported for this patient. The product expired on 18-Jan-2010 and was administered to the patient on 28-Jan-2010. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Age: 6.0
Sex: F
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of "administration of expired product" was received from a registered nurse concerning a six-year-old female subsequent to FLUMIST. The patient's medical history and concomitant medications were not reported. The product expired on 19-Jan-2010. On 01-Feb-2010, the patient received expired product. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Age: 6.0
Sex: M
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of "administration of expired product" was received from a registered nurse concerning a six-year-old male subsequent to FLUMIST. The patient's medical history and concomitant medications were not reported. The product expired on 19-Jan-2010. On 01-Feb-2010, the patient received expired product. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Age: 5.0
Sex: M
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of "administration of expired product" was received from a registered nurse concerning a five-year-old male subsequent to FLUMIST. The patient's medical history and concomitant medications were not reported. The product expired on 19-Jan-2010. On 01-Feb-2010, the patient received expired product. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Age: 5.0
Sex: F
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of "administration of expired product" was received from a registered nurse concerning a five-year-old female subsequent to FLUMIST. The patient's medical history and concomitant medications were not reported. The product expired on 19-Jan-2010. On 27-Jan-2010, the patient received expired product. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Sex: U
Vaccine: FLUN3
Symptoms: Expired drug administered, No adverse event
Clinical narrative: A non-serious spontaneous report of "a patient received a dose of expired FLUMIST" was received from a health care professional concerning an adult of unknown age and sex. The patient's medical history and concomitant medications were not reported. On 21-Dec-2009, the patient was administered FLUMIST with expiration date of 08-Dec-2009. The lot number was unavailable. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
Age: 55.0
Sex: F
Vaccine: FLUN3
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: A non-serious spontaneous report of "we gave FLUMIST to a 55 year old female" has been received from a registered nurse concerning a 55-year-old female patient, subsequent to FLUMIST. The patient's medical history and concomitant medications were not reported. On 28-Dec-2009, the patient was inadvertently administered FLUMIST in the reporter's facility. There was no adverse event associated with this vaccination error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved as of 29-Dec-2009.
Age: 37.0
Sex: M
Vaccine: FLUN3
Symptoms: Cough, Malaise, Multiple allergies, Pyrexia, Sinusitis
Clinical narrative: A non-serious, spontaneous report of "sick with fever, coughing, sinusitis and allergies since getting FLUMIST in October" has been received from a 37-year-old male consumer subsequent to FLUMIST. The patient's medical history and concomitant medications were not reported. The patient received FLUMIST on 26-Oct-2009. Since 28-Oct-2009, the patient has been sick with fever, cough, sinusitis and allergies. The adverse events have not resolved.
Age: 62.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Injection site swelling, Pyrexia
Clinical narrative: pain at injection site, redness, swelling, fever
Age: 62.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Erythema, Injection site pain, Pyrexia, Swelling
Clinical narrative: pain at injection site, redness, swelling, fever
Age: 1.3
Sex: M
Vaccine: DTAP
Symptoms: Chest X-ray, Cough, Lethargy, Pneumonia, Pyrexia
Clinical narrative: Runny nose, Cough, Rapid breathing, high fever, lethargic, diagnosed with Pnuemonia, started antibiotic treatment, still in progress.
Age: 1.3
Sex: M
Vaccine: DTAP
Symptoms: Respiratory rate increased, Rhinorrhoea
Clinical narrative: Runny nose, Cough, Rapid breathing, high fever, lethargic, diagnosed with Pnuemonia, started antibiotic treatment, still in progress.
Sex: F
Vaccine: HPV4
Symptoms: Deafness
Clinical narrative: Information has been received from a physician. The physician recommended one of her patients to receive GARDASIL, but the patient's mother said no because one of her friends who was a physician, their daughter received a dose of GARDASIL, and subsequently experienced deaf. At the time of reporting, the outcome was unknown. It is unknown if the patient sought medical attention. Upon internal review, deaf was determined to be an other important medical event. No further information is available.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Dyspnoea
Clinical narrative: Information has been received from a registered nurse concerning a 12 year old female patient with no pertinent medical history who on an unknown date was vaccinated with her first dose of GARDASIL. About 6 hours after receiving her first dose of GARDASIL, the patient developed shortness of breath. She went to the Emergency Room but was not admitted to the hospital. No specific treatment was given. The patient had gone to two different doctors and was still experiencing symptoms. The reporting registered nurse considered "shortness of breath" to be an other important medical event due to visit to the Emergency Room. No further information is available.
Age: 11.0
Sex: M
Vaccine: VARCEL
Symptoms: Emotional distress, Inflammation, Injection site erythema, Injection site pain, Injection site pruritus
Clinical narrative: Information has been received from a medical assistant concerning her 11 year old son with no known drug allergies or pertinent medical history who "maybe in 2004" was vaccinated with the first dose of VARIVAX (Merck) (lot number not provided). On 28-JUL-2010 the patient received the second dose of VARIVAX (Merck) (lot number not provided). There was no concomitant medication. The medical assistant reported that on 28-JUL-2010, later in the day, the patient had a bright red spot at the injection site. The entire length of 3 inches down from the injection site, the arm was inflamed, swollen at the injection site, hot, itchy and painful. The patient was taken back to the physician office the same day twice. The patient was given topical cream to apply to the affected area and BENADRYL orally in the evening that cleared the inflammation a little and the pain went away. The inflammation, swelling, hot, itchy and painful reaction was gone but there was still a red shadow in the 3 inch area that looked like "burned skin". No laboratories tests were performed. Bright red spot at the injection site, the arm was inflamed, swollen at the injection site, hot, itchy and painful were considered to be disabling by the medical assistant because her son was distressing in the evening. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a medical assistant concerning her 11 year old son with no known drug allergies or pertinent medical history who "maybe in 2004" was vaccinated with the first dose of VARIVAX (Merck) (lot number not provided). On 28-JUL-2010 the patient received the second dose of VARIVAX (Merck) (lot number not provided). There was no concomitant medication. The medical assistant reported that on 28-JUL-2010, later in the day, the patient had a bright red spot at the injection site. The entire length of 3 inches down from the injection site, the arm was inflamed, swollen at the injection site, hot, itchy and painful. The patient was taken back to the physician office the same day twice. The patient was given topical cream to apply to the affected area and BENADRYL orally in the evening that cleared the inflammation a little and the pain went away. The inflammation, swelling, hot, itchy and painful reaction was gone but there was still a red shadow in the 3 inch area that looked like "burned skin". No laboratories tests were performed. Bright red spot at the injection site, the arm was inflamed, swollen at the injection site, hot, itchy and painful were considered to be disabling by the medical assistant because her son was distressing in the evening. Additional information has been requested.
Sex: M
Vaccine: DTAPIPV
Symptoms: Hyperaesthesia, Injection site erythema, Injection site swelling
Clinical narrative: Notice today. No itch, c/o pain. No pain only touch. 5.5cm x 5cm. Redness slightly swollen.
Age: 1.67
Sex: M
Vaccine: DTAP, HEPA, HIBV, MMR, PNC13, VARCEL
Symptoms: Injection site erythema, Injection site mass, Injection site pain
Clinical narrative: Pt. received vaccination last 8/12/10. Came back today (8/16/10) with a 1.5 cm x 1.5 cm bump on (R) thigh. (+) redness, tender to touch.
Age: 0.99
Sex: F
Vaccine: MMR, PNC13, VARCEL
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Child was given MMR and Varicella prior to first birthday.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Rash, Rash erythematous, Skin lesion, Urticaria
Clinical narrative: Had hives and rash 2 hours after vaccine. Improved with BENADRYL. She had erythematous hive-like lesions on knees, and upper extremities.
Age: 8.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Injection site erythema, Injection site rash, Injection site swelling, Injection site vesicles
Clinical narrative: Vaccine site, L upper arm, with erythema mild swelling & vesicular erupting 4 x 4 cm area.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, MMR
Symptoms: Injection site erythema, Injection site swelling, Pyrexia, Vomiting
Clinical narrative: Redness, swollen, feverish and vomiting; took TYLENOL for symptoms. Father said seems to react more to insect bites than used to wonders if she is developing allergies.
Age: 13.0
Sex: M
Vaccine: HEPA, MNQ
Symptoms: Body temperature increased, Rash, Swelling face, Vomiting
Clinical narrative: 8/12/10 Temp 102, vomiting, rash on lower face, cheeks swollen.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Grand mal convulsion, Head injury, Headache, Hyperhidrosis
Clinical narrative: Patient had generalized tonic clonic seizure lasting approximately 5 seconds a few minutes after receiving GARDASIL #1. This was followed by dizziness, diaphoresis, sore throat & headache. Patient may have hit head against wall during the seizure.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Oropharyngeal pain
Clinical narrative: Patient had generalized tonic clonic seizure lasting approximately 5 seconds a few minutes after receiving GARDASIL #1. This was followed by dizziness, diaphoresis, sore throat & headache. Patient may have hit head against wall during the seizure.
Age: 16.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Nausea, Vertigo, Vestibular function test
Clinical narrative: Vertigo & nausea for last 3 days. Meds tried: TYLENOL & SUDAFED. Referred to physical therapy for eval.
Age: 14.0
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: Syncope
Clinical narrative: Pt fainted - given Ammonia lasting approx 1 min.
Age: 2.0
Sex: M
Vaccine: HEPA, PNC13
Symptoms: Injection site erythema, Injection site swelling, Pruritus, Pyrexia
Clinical narrative: 10x6cm swollen and red area to left leg at PCV 13 site. Fever 100 - per mom NL at visit put on ATARAX for itching.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Cervical dysplasia, Papilloma viral infection
Clinical narrative: 1st pap: 7/21/2010 @ 17 y.o. results = low grade squamous intraepithelial lesion (C1NI/HPV effect).
Age: 6.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMRV
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Developed redness, swelling, itching on (R) anterior thigh just distal to injection site.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash, Rash papular
Clinical narrative: Rash developed/discovered 8/7 on the arm the injection was injected small papules developed on that arm but not everywhere pt also stated she was on Aldora at the time of injection. No treatment yet.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, HEPA
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Redness and pain at the injection site.
Age: 27.0
Sex: M
Vaccine: SMALL, YF
Symptoms: Headache, Nausea, Pyrexia
Clinical narrative: Flu like symptoms nausea, soreness in muscles and joints w/ associated weakness in muscles. Fever running 101 degrees throughout night headache and pain behind eyes.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Redness, warmth, induration at site of vaccination approx 3cm X 5cm, (R) deltoid at noon on 8/11/10.
Age: 9.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Blister, Erythema, Skin lesion, Skin warm
Clinical narrative: 7cm erythematous raised lesion warm to touch on day two on day three the lesion is still erythematous and warm to touch and covered in fluid filled (clear) vesicles of various sizes.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, PNC13, VARCEL
Symptoms: Rhinorrhoea, Urticaria
Clinical narrative: Patient developed small whelps on face and neck. No wheezing occurred but positive clear Rhinnorrhea. Reaction happened around 4 pm. BENADRYL was given (1 1/2 tsp po at 4:03 pm. Then patient was assessed again at 4:20pm and  had very faint raised small whelps. Pt was well & active & much improved.
Age: 0.5
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Pyrexia
Clinical narrative: Fever of 104.1 rectally. Legs did not want to be moved. Parent's given TYLENOL. On 8-13-10 morning still having fever 101. Pt also had phimosis at time of follow up exam.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site haemorrhage, Injection site induration, Injection site swelling
Clinical narrative: Left thigh with blotchy erythematous area approx 3" in diameter at its widest - firm and swollen. The lateral portion of this noted faintly ecchymotic area approx dime size. Started on KEFLEX 250mg/5ml 2 tsp PO TID 7 days and BENADRYL for wt.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Body temperature increased, Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Redness, swelling, itching at site. Temperature 100.3.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Computerised tomogram, Dyspnoea, Pneumothorax
Clinical narrative: Patient suffered shortness of breath with spontaneous pneumothorax. T 97.1.
Age: 49.0
Sex: F
Vaccine: FLUX, FLUX(H1N1)
Symptoms: Injected limb mobility decreased, Oedema peripheral, Pain in extremity, Tenderness
Clinical narrative: My right upper arm got sore & is still very sore to the point I have trouble moving it. It at first swelled up but went down but stayed tender to touch.
Age: 32.0
Sex: M
Vaccine: HEP, TDAP
Symptoms: Chest pain, Rash
Clinical narrative: Pt. reports on 7/24/2010, he noted pain in left upper chest, (L) nipple and (L) upper back. Pain was severe enough to require Ibuprofen. On 7/26/10, pt noted rash at (L)  upper chest and (L) upper back. Presents to clinic today, 7/28/10 due to concerns that he is experiencing vaccine related side effects. Patient referred to doctor for evaluation of rash and pain.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Abnormal dreams, Clonus, Faecal incontinence, Immediate post-injection reaction, Nausea
Clinical narrative: Before administering vaccine discussed possible SE's & denied previous syncope or presyncope with HPV #1 vaccine. This pt provided with HPV #2 vaccine and w/in 5 seconds of injection pt had full syncopal episode with clonic like behavioral as well as loss of bowel control & a vivid dream. Pt denied post-injection or post syncopal confusion. Pt laid down with improvement, but did develop n/v.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: No reaction on previous exposure to drug, Syncope, Vomiting
Clinical narrative: Before administering vaccine discussed possible SE's & denied previous syncope or presyncope with HPV #1 vaccine. This pt provided with HPV #2 vaccine and w/in 5 seconds of injection pt had full syncopal episode with clonic like behavioral as well as loss of bowel control & a vivid dream. Pt denied post-injection or post syncopal confusion. Pt laid down with improvement, but did develop n/v.
Age: 57.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Pt complaint of redness, swelling, warm to touch at injection site. 4 days after receiving injection. Pt seen by Dr 8/10/10. Instructed localized reaction to vaccine. To F/U 8/11/10 or sooner.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Breast enlargement
Clinical narrative: Mom alleges that childs breast asymmetry (Rt breast larger) was caused by HPV vaccine?
Age: 9.0
Sex: F
Vaccine: HEPA, HPV4
Symptoms: Breast malformation
Clinical narrative: Mom alleges that child's breast asymmetry was caused by HPV vaccine (left breast smaller).?
Sex: M
Vaccine: DTAP, HEPA
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Left arm redness, sore, swelling 2 hrs after shot - DTAP given.
Age: 0.09
Sex: M
Vaccine: HEPA
Symptoms: Wrong drug administered
Clinical narrative: Dr. asked I give patient a Hepatitis B vaccine and in error I gave Hepatitis A vaccine.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Fall, Syncope
Clinical narrative: syncope and possible black out and fall
Age: 82.0
Sex: M
Vaccine: VARZOS
Symptoms: Back pain, Balance disorder, Dizziness, Headache, Malaise
Clinical narrative: The patient states that after the shingles shot, he felt very sick and lousy severely for 2 days.  Ever since then he has not felt quite right, complaining of feeling woozy, off balance, and visual symptoms that do not seem to be corrected over glasses.  He does note that his daughter contracted Guillain-Barre syndrome after receiving the flu vaccine. Patient states his symptoms are persistent but do not occur every day. He has good and bad days, whereas in the beginning he had mostly bad days.  He also had associated headache and he still gets a headache from time to time now with severe back pain going from his low back to his neck.  He has got a chronic rhinitis since the vaccination as well.  He did not complain of any headaches prior to the injections.
Age: 82.0
Sex: M
Vaccine: VARZOS
Symptoms: Rhinitis, Visual impairment
Clinical narrative: The patient states that after the shingles shot, he felt very sick and lousy severely for 2 days.  Ever since then he has not felt quite right, complaining of feeling woozy, off balance, and visual symptoms that do not seem to be corrected over glasses.  He does note that his daughter contracted Guillain-Barre syndrome after receiving the flu vaccine. Patient states his symptoms are persistent but do not occur every day. He has good and bad days, whereas in the beginning he had mostly bad days.  He also had associated headache and he still gets a headache from time to time now with severe back pain going from his low back to his neck.  He has got a chronic rhinitis since the vaccination as well.  He did not complain of any headaches prior to the injections.
Age: 4.0
Sex: M
Vaccine: PNC13
Symptoms: Hypersensitivity, Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: PATIENT RETURNED TO CLINIC THE DAY AFTER THE INJECTION OF PCV13 IN RIGHT DELTOID WITH COMPLAINTS OF ITCHING AT SITE, DENIAL OF PAIN, MINIMAL SWELLING, MINIMAL HEAT AT INJECTION SITE AND REDNESS DOWN TO RIGHT ELBOW AND UNDER ARM. PATIENT INFORMED BY DR. THAT IT WAS AN ALLERGIC REACTION AND PATIENT WAS GIVEN INSTRUCTIONS ON ADMINISTERING BENADRYL BASED ON HIS WEIGHT. PATIENT RETURNED TO CLINIC 8/16/10 WITH COMPLAINTS OF FINGER TIPS PEELING, HOWEVER, AFTER BEING EXAMINED BY THE DOCTOR, HE ALSO HAD A "STRAWBERRY COLORED" TONGUE. DR. EXPLAINED THIS WAS NOT RELATED TO THE VACCINE, THIS WAS RELATED TO THE STREP DIAGNOSIS ON 8/5/10 AND HE WAS PRESCRIBED ANOTHER ANTIBIOTIC.  PATIENT'S ARM HAD COMPLETELY RESOLVED WITH NO FURTHER COMPLAINTS.
Age: 4.0
Sex: M
Vaccine: PNC13
Symptoms: Skin exfoliation, Strawberry tongue
Clinical narrative: PATIENT RETURNED TO CLINIC THE DAY AFTER THE INJECTION OF PCV13 IN RIGHT DELTOID WITH COMPLAINTS OF ITCHING AT SITE, DENIAL OF PAIN, MINIMAL SWELLING, MINIMAL HEAT AT INJECTION SITE AND REDNESS DOWN TO RIGHT ELBOW AND UNDER ARM. PATIENT INFORMED BY DR. THAT IT WAS AN ALLERGIC REACTION AND PATIENT WAS GIVEN INSTRUCTIONS ON ADMINISTERING BENADRYL BASED ON HIS WEIGHT. PATIENT RETURNED TO CLINIC 8/16/10 WITH COMPLAINTS OF FINGER TIPS PEELING, HOWEVER, AFTER BEING EXAMINED BY THE DOCTOR, HE ALSO HAD A "STRAWBERRY COLORED" TONGUE. DR. EXPLAINED THIS WAS NOT RELATED TO THE VACCINE, THIS WAS RELATED TO THE STREP DIAGNOSIS ON 8/5/10 AND HE WAS PRESCRIBED ANOTHER ANTIBIOTIC.  PATIENT'S ARM HAD COMPLETELY RESOLVED WITH NO FURTHER COMPLAINTS.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling, Local reaction
Clinical narrative: Local reaction - erythema mild swelling - about 5 cm.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Rash, Urticaria
Clinical narrative: Approx 24 hrs after injections and after karate practice child broke out in hives starting at back of neck, trunk then extremities. No other sx exhibited. Treated with BENADRYL. Still has a few hives or rash  like bump 2 days after.
Age: 11.0
Sex: F
Vaccine: HEPA, TDAP, VARCEL
Symptoms: Anxiety, Asthenia, Dizziness, Feeling hot, Nausea
Clinical narrative: Child was anxious & giggly before injections. Apx 5-10 afterward, became light headed, hot, sl nausea, gave sucker. Stood up to ambulate after walking forward got weak, sat down then fainted. Was slow for weakness to resolve, gave 5 cc BENADRYL. (8/16 - child doing fine per grandparent).
Age: 11.0
Sex: F
Vaccine: HEPA, TDAP, VARCEL
Symptoms: Syncope
Clinical narrative: Child was anxious & giggly before injections. Apx 5-10 afterward, became light headed, hot, sl nausea, gave sucker. Stood up to ambulate after walking forward got weak, sat down then fainted. Was slow for weakness to resolve, gave 5 cc BENADRYL. (8/16 - child doing fine per grandparent).
Age: 59.0
Sex: F
Vaccine: TDAP
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Pt was give two TDAP within 5 month of each other. Dr contacted pt told pt to call if she had any problems.
Age: 1.1
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Decreased appetite, Irritability, Rash erythematous
Clinical narrative: Developed red spots that resemble chicken pox. Decreased appetite, cranky.
Age: 14.0
Sex: M
Vaccine: TDAP
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: 8-12-10 Tdap (BOOSTRIX) administered then information received from previous provider that on 5-5-06 Tdap (ADACEL) was administered. 8/17/10 spoke to mother - no adverse reaction reported.
Age: 23.0
Sex: F
Vaccine: MMR, TDAP
Symptoms: Rash morbilliform
Clinical narrative: Morbilliform rash on legs, arms, and back.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Injection site swelling, Pyrexia
Clinical narrative: Left ant. leg swollen after KINRIX administered. Slight low grade fever 24 hrs after vaccine.
Age: 52.0
Sex: F
Vaccine: TDAP
Symptoms: Inappropriate schedule of drug administration, Injection site pain
Clinical narrative: Employee received 2 TDAP vaccines within a 2 year time frame. Reported severe local pain at injection site X 3 days.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Loss of consciousness
Clinical narrative: C/o felt light headed, after telling her mom this pt took off in a run. Pt found in floor a few feet away from checkout desk, this occurred within 10 min of receiving vaccine for HPV GARDASIL. Pt assisted to w/c and rested in treatment room. BP originally 94/34 after resting a few minutes 100/70. Checked by office PNP and released home with mom.
Age: 0.69
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Injection site rash, Injection site swelling
Clinical narrative: Vaccine local reaction. No need to further deter DTaP. Lt anterior thigh with flat macula rash. Swelling injection site. If worsen or develop further s+s RTC.
Age: 12.0
Sex: M
Vaccine: MMR, MNQ, TDAP
Symptoms: Loss of consciousness, Syncope
Clinical narrative: After receiving three vaccines, child had apparent vaso-vagal event, syncope, loss of consciousness, lasting approx. 30sec. Child was seated. Head lowered. BP 118/74, P 72/reg. Observed for 30" before releasing. Dad present entire time.
Age: 39.0
Sex: M
Vaccine: ANTH, TYP
Symptoms: Erythema, Induration, Injection site swelling
Clinical narrative: On 8-15-10 I noticed swelling and redness going a couple of inches behind my arm and the next day got harder and I got some redness and hardness towards the front of my arm also the area of injection was getting larger.
Age: 11.0
Sex: M
Vaccine: HEPA, MNQ, TDAP
Symptoms: Abdominal pain upper, Back pain, Chills, Headache, Pyrexia
Clinical narrative: The night of that he recieved his Tdap, Hep A, and Menactra he c/o stomach ache and ran 103 fever. For 5 days he ran 102-104 fever, had chills, headache, and backpain. No coughing, no sore throat and no rhinorrhea.
Age: 16.0
Sex: F
Vaccine: HEPA, HPV4, IPV, MNQ, TTOX
Symptoms: Hyperhidrosis, Pallor, Unresponsive to stimuli
Clinical narrative: During the process of vaccinating the client with HPV, she became pale, diaphoretic and non compliant to verbal orders. Cold water compress was applied to neck and face, Vital signs were obtained. Patient was given orange juice prior to immunizations after admitting not eating that A.M. A second can of orange juice was given after patient bacame more responsive. Patient was walked to alternate room and allowed to lie down until she felt better. Patient left with Guardian under own power.
Age: 13.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Asthenia, Body temperature increased, Culture throat negative, Oropharyngeal pain, Streptococcus test
Clinical narrative: Patient was seen the day after immunization with c/o profound weakness, T 101.7 HR116 BP 102/60 c/o sore throat, tongue swelling but no sob, dysphagia.
Age: 13.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Swollen tongue
Clinical narrative: Patient was seen the day after immunization with c/o profound weakness, T 101.7 HR116 BP 102/60 c/o sore throat, tongue swelling but no sob, dysphagia.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMRV
Symptoms: Injection site cellulitis, Pyrexia
Clinical narrative: Fever; Cellulitis Left arm
Age: 15.0
Sex: F
Vaccine: FLUN3
Symptoms: Headache, Pyrexia, Rhinorrhoea, Sinusitis
Clinical narrative: Low-grade temp, runny nose, sinusitis, headache.
Age: 10.0
Sex: F
Vaccine: FLUN3
Symptoms: Body temperature increased, Rhinorrhoea, Sinusitis
Clinical narrative: Low-grade temp, runny nose, sinusitis.
Age: 11.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP, VARCEL
Symptoms: Dyspnoea, Injection site erythema, Injection site swelling, Injection site urticaria, Injection site warmth
Clinical narrative: (L) thigh, welt 3 1/2 x 4 1/2 wide red, hot to touch, swollen. Cold packs Ibuprofen and TYLENOL, Heat packs, trouble breathing x 4 days treated w/antibiotic.
Age: 3.0
Sex: M
Vaccine: PNC13, PNC13
Symptoms: Body temperature increased, Injection site cellulitis, Injection site erythema, Injection site induration, Injection site macule
Clinical narrative: Patient was seen for swollen (L) arm at site of injection. It was an oval 4 x 5 cm red macular rash, hot to touch, induration and tender. Rash was progressing towards shoulder jt - Temp 100.1 child appeared well, full range of motion - Explained to mom this was cellulitis - AUGMENTIN x 10d. Follow up if rash progressed up/any other signs.
Age: 3.0
Sex: M
Vaccine: PNC13, PNC13
Symptoms: Injection site pain, Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: Patient was seen for swollen (L) arm at site of injection. It was an oval 4 x 5 cm red macular rash, hot to touch, induration and tender. Rash was progressing towards shoulder jt - Temp 100.1 child appeared well, full range of motion - Explained to mom this was cellulitis - AUGMENTIN x 10d. Follow up if rash progressed up/any other signs.
Age: 3.0
Sex: M
Vaccine: PNC13, PNC13
Symptoms: Abnormal behaviour, Contusion, Erythema, Pyrexia, Rash
Clinical narrative: Patient was seen for swollen (L) arm at site of injection. It was an oval 4 x 5 cm red macular rash, hot to touch, induration and tender. Rash was progressing towards shoulder jt - Temp 100.1 child appeared well, full range of motion - Explained to mom this was cellulitis - AUGMENTIN x 10d. Follow up if rash progressed up/any other signs.
Age: 3.0
Sex: M
Vaccine: PNC13, PNC13
Symptoms: Skin discolouration, Skin irritation, Skin warm
Clinical narrative: Patient was seen for swollen (L) arm at site of injection. It was an oval 4 x 5 cm red macular rash, hot to touch, induration and tender. Rash was progressing towards shoulder jt - Temp 100.1 child appeared well, full range of motion - Explained to mom this was cellulitis - AUGMENTIN x 10d. Follow up if rash progressed up/any other signs.
Age: 3.0
Sex: M
Vaccine: HIBV, PNC13
Symptoms: Injection site erythema, Injection site swelling, Injection site vesicles, Wheezing
Clinical narrative: Giant patch redness and swelling from site of injection (Deltoid) down entire up arm, sl. blister 2 episodes of wheezing.
Age: 1.57
Sex: F
Vaccine: DTAP, HEPA, IPV
Symptoms: Incorrect dose administered
Clinical narrative: Adult dose HEP A given instead of pediatric dose - no signs/symptoms - patient was seen in office for recheck 8/13/10 and discussed with parents.
Age: 2.0
Sex: M
Vaccine: PNC13
Symptoms: Injection site rash
Clinical narrative: Local reaction to vaccination (L) anterior thigh with minimal flat rash surrounding injection site with no edema no limping with walking.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Pruritus
Clinical narrative: Local erythematous allergic response of (L) deltoid. Pt complained of itching and was treated with 25 mg BENADRYL.
Age: 41.0
Sex: F
Vaccine: TD
Symptoms: Headache, Injection site pain, Injection site warmth, Pyrexia, Rash erythematous
Clinical narrative: Td vaccine administered 4/12/2010. Next day developed pain in site of injection/headache mild fever (T max 100 degrees F). This morning noted erythematous area 7 cm x 4.5 cm with high local temp Lt deltoid area (area of injection).
Age: 66.0
Sex: F
Vaccine: FLUX
Symptoms: Injection site erythema, Injection site rash, Injection site warmth
Clinical narrative: Pt. received flu shot on 8-14-10. Patient came in to the pharmacy on 8-16-10 and had redness and a rash that was warm to touch at site of shot.
Age: 12.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP
Symptoms: Erythema, Induration, Pain, Swelling
Clinical narrative: 12 yo female with increased redness, swelling induration 48 hrs after vaccine given- (Tdap) with increased pain. 3.2 x 4.5cm area of induration no redness no fever.